Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

49.29 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 245
Open 49.29
Bid (Size) 48.65 (100)
Ask (Size) 49.80 (200)
Prev. Close 49.29
Today's Range 49.29 - 49.29
52wk Range 30.04 - 78.48
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
Boston, MA – November 19, 2025 – Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) experienced a dramatic and immediate market backlash, with its stock plummeting over 51.00% following the announcement of... 
Via MarketMinute
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
These stocks both have advanced in the double-digits in recent months. 
Via The Motley Fool

Performance

YTD
+19.0%
+19.0%
1 Month
-31.8%
-31.8%
3 Month
-6.7%
-6.7%
6 Month
+31.3%
+31.3%
1 Year
+4.3%
+4.3%

More News

Read More
News headline image
1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗
Via The Motley Fool
Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70% ↗
Via Stocktwits
News headline image
The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial ↗
Via Benzinga
News headline image
Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
Via Investor's Business Daily
Topics Death
News headline image
Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗
Via Investor's Business Daily
Topics Death
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
News headline image
Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗
Via Benzinga
News headline image
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
Via Benzinga
News headline image
2 Soaring Cathie Wood Stocks to Buy and Hold ↗
Via The Motley Fool
News headline image
New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. ↗
Via The Motley Fool
News headline image
3 Monster Stocks to Hold for the Next 10 Years ↗
Via The Motley Fool
News headline image
4 Healthcare Stocks to Buy Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗
Via The Motley Fool
Topics Government World Trade
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
News headline image
3 Growth Stocks That Could Be 10-Baggers in 10 Years ↗
Via The Motley Fool
News headline image
Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗
Via The Motley Fool
News headline image
Could This Beaten-Down Stock Help You Become a Millionaire? ↗
Via The Motley Fool
Topics ETFs

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 49.29
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 11/20/25 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 3.89B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.